XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 115 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. More effective stem cell transplant method could aid blood cancer…

    https://www.ucl.ac.uk/cancer/news/2020/mar/more-effective-stem-cell-transplant-method-could-aid-blood-cancer-patients

    26 Mar 2020: Researchers at UCL have developed a new way to make the blood stem cells present in the umbilical cord ‘more transplantable’, a finding which could improve the treatment of a wide range of blood diseases in children and adults.

    Researchers at UCL have developed a new way to make the blood stem cells present in the umbilical cord ‘more transplantable’, a finding which could improve the treatment of a wide range of blood diseases in children and adults.

  2. Professor Bart Vanhaesebroeck to receive Excellence in Science award…

    https://www.ucl.ac.uk/cancer/news/2020/mar/professor-bart-vanhaesebroeck-receive-excellence-science-award

    24 Mar 2020: The Biochemical Society have announced that the 2021 Portland Press Excellence in Science Award will be presented to Professor Bart Vanhaesebroeck in recognition of his pioneering work on PI 3-kinase (PI3K) signalling enzymes.

    The Biochemical Society have announced that the 2021 Portland Press Excellence in Science Award will be presented to Professor Bart Vanhaesebroeck in recognition of his pioneering work on PI 3-kinase (PI3K) signalling enzymes.

  3. Cancer’s ‘genome doubling’ mystery solved | UCL Cancer Institute -…

    https://www.ucl.ac.uk/cancer/news/2020/mar/cancers-genome-doubling-mystery-solved

    10 Mar 2020: Researchers at the Crick and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.

    Researchers at the Crick and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.

  4. Prostate cancer ‘fingerprint’ detected in blood sample | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2020/mar/prostate-cancer-fingerprint-detected-blood-sample

    10 Mar 2020: Scientists at UCL have developed a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better treatment selection.

    Scientists at UCL have developed a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better treatment selection.

  5. How cancer cells communicate shown for first time | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2020/feb/how-cancer-cells-communicate-shown-first-time

    19 Feb 2020: New technology developed at UCL is, for the first time, enabling cancer scientists to analyse the individual behaviour of millions of different cells living inside lab-grown tumours – a breakthrough which could lead to new personalised cancer

    New technology developed at UCL is, for the first time, enabling cancer scientists to analyse the individual behaviour of millions of different cells living inside lab-grown tumours – a breakthrough which could lead to new personalised cancer

  6. Protective cells could cut risk of lung cancer for ex-smokers | UCL…

    https://www.ucl.ac.uk/cancer/news/2020/jan/protective-cells-could-cut-risk-lung-cancer-ex-smokers

    30 Jan 2020: Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer, finds new research co-led by UCL and the Wellcome Sanger Institute.

    Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer, finds new research co-led by UCL and the Wellcome Sanger Institute.

  7. Immune cell discovery opens door to new powerful cancer therapies |…

    https://www.ucl.ac.uk/cancer/news/2020/jan/immune-cell-discovery-opens-door-new-powerful-cancer-therapies

    7 Jan 2020: Scientists at UCL have identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.

    Scientists at UCL have identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.

  8. Opinion: Prostate cancer screening 'in sight' | UCL Cancer Institute…

    https://www.ucl.ac.uk/cancer/news/2019/dec/opinion-prostate-cancer-screening-sight

    19 Dec 2019: Professor Mark Emberton, Dean of the Faculty of Medical Sciences, writes about the new UCL-led trial, which is testing to see if MRI scans could be effective at screening men for prostate cancer, in a similar way to how mammograms are used to check

    Professor Mark Emberton, Dean of the Faculty of Medical Sciences, writes about the new UCL-led trial, which is testing to see if MRI scans could be effective at screening men for prostate cancer, in a similar way to how mammograms are used to check

  9. One dose of radiotherapy as effective as five doses for cancer in the …

    https://www.ucl.ac.uk/cancer/news/2019/dec/one-dose-radiotherapy-effective-five-doses-cancer-spine

    3 Dec 2019: A single dose of radiotherapy is as “effective” as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

    A single dose of radiotherapy is as “effective” as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

  10. Next generation of cancer drugs focus of new Japanese partnership |…

    https://www.ucl.ac.uk/cancer/news/2019/nov/next-generation-cancer-drugs-focus-new-japanese-partnership

    25 Nov 2019: Researchers at UCL will lead groundbreaking cancer research which aims to identify vulnerabilities resulting from mutated DNA in cancers, as part of a new international drug target discovery alliance.

    Researchers at UCL will lead groundbreaking cancer research which aims to identify vulnerabilities resulting from mutated DNA in cancers, as part of a new international drug target discovery alliance.

Pagination

Refine

Subjects

Organisational Units : all → cancer institute

Communication types

Audiences